118 Infos zu Stephan Glund

7 Aktuelle Nachrichten

— ... study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa. › health

An experimental antidote to the widely used blood clot preventer Pradaxa worked immediately and completely in an early-stage trial among healthy volunteers,...

... clinical study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa.

In early tests, new drug allowed blood to clot again with no apparent side effects

3 Profile in Sozialen Netzwerken

› stephan-glund-a

Niche Science & Tech · @niche_science. ·. May 15, Biologicals are not just “big chemicals” - key learnings from Stephan Glund at #eufemed Image. › hashtag

3 Hobbys & Interessen

... healthy volunteers, showing that idarucizumab reversed the anticoagulant effects of dabigatran," said lead investigator Stephan Glund, PhD, ...

Paul A. Reilly, Joanne van Ryn, Oliver Grottke, Stephan Glund, Joachim Stangier. Iconography · @@# @@. Review. Evidence Supporting Idarucizumab ...

· Paul A. Reilly, PhD , Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, PhD. a Clinical Development ...

1 Ärzte & Mediziner

— Stephan Glund i wsp. przeanalizowali bezpieczeństwo oraz efektywność wzrastających dawek idarucizumabu, stosowanego celem odwrócenia efektu ... › Idaruciz...

1 Business-Profile

› Step...

4 Persönliche Webseiten

Swedish University dissertations (essays) about STEPHAN GLUND. Search and download thousands of Swedish university dissertations. Full text. Free.

Ze schreven dat omdat Stephan Glund e.a. middels een placebogecontroleerd fase I-onderzoek bij 47 gezonde mannen het effect van idarucizumab in verschillende doses op de stolling nagingen en primair de veiligheid van het middel beoordeelden. Bij drie deelnemers traden symptomen van ...

11. · Robby Zachariah Tom ·; ; 12. · Jan Aydin ·; ; 13. · Stephan Glund ·; AMP-activated protein kinase; interleukin-6; exercise; glucose metabolism; lipid ... › about

— Stephan Glund en zijn collega's van farmaceut Boehringer-Ingelheim publiceren hierover in The Lancet. Zij keken middels een ... › o...

11 Bücher zum Namen

von T Hardman · · Zitiert von: 1 — Stephan Glund (Boehringer Ingelheim, Germany) discussed how biological agents differ markedly in size and complexity. › publication › file

Radcliffe Cardiology article authored by Stephan Glund covering topics in cardiology field

The American Heart Association’s Scientific Sessions is bringing big science, big technology, and big networking opportunities to New Orleans, Louisiana...

... Boehringer Ingelheim, Ridgefield, CT; Joanne van Ryn, Boehringer Ingelheim, Biberach, Germany; Stephan Glund, Boehringer Ingelheim Pharma GmbH & Co.

9 Dokumente

MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.

AHA Conference Preview

SUSANNE SALES, UTA BURO, BRAD HAMILTON, STEPHAN GLUND, STEFAN R. BORNSTEIN, MONIKA EHRHART-BORNSTEIN P Dresden, Germany, Biberach, Germany Human. › a...

Authors: Stephan Glund, Joachim Stangier, Michael Schmohl, Boehringer Ingelheim GmbH & Co. KG, Biberach an der Riss, Germany; Marina ...

3 Wissenschaftliche Publikationen

9） Stephan Glund, et al: Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male ... › -char

— Reilly, Joanne van Ryn, John W. Eikelboom, Stephan Glund, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Chak-Wah Kam, ... ›

4 Allgemeine Veröffentlichungen

Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation. Safety, pharmacokinetics and pharmacodynamics of idaru

Dr. Stephan Glund. Head of Clinical Pharmacology CREA. Boehringer Ingelheim Pharma GmbH & Co. KG. Biberach (Germany). Dr. Roland Heinig. Stephan Glund, Biberach (Germany). 09:15, Human PK – What's different in biologics? Part 1. An introduction into bioanalytical methods, antibody development ... › wp-content › uploads › AG... › event › aga...

68 Webfunde aus dem Netz

... and Safety and Efficacy in Phase 1 Subjects Paul A. Reilly, PhD, Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, ... › slide

· Stephan Glund, Biberach (Germany) Break: 10:15 Human PK – What’s different in biologics? Part 2. An introduction into bioanalytical methods, antibody development …

› Step...

7c Thomas Fox / Sabine Schnatz 10c Stephan Glund / Sandra Stopfer Wolfgang Sell 7d Andreas Köhler / Hanno Hohenberger 10d Sandra Traulsen / Monika Wille Holger Rosenbrock …

A nem-K vitamin antagonista orális antikoagulánsok hatását visszafordító speciális kezelés nem áll rendelkezésre. Az idarucizumab egy antitest-fragmentum, amit...

Stephan Glund S et al. Circulation 2013;128:A Ryn J et al. Thromb Haemost 2010;103:1116– Beyer-Westendorff J et al. Blood 2014;124: Über uns. cme …

... Stephan Glund, Atul Deshmukh, Ditte K. Klein, Yun Chau Long, Thomas E. Jensen, . Source: Diabetes. Document Type: Disease/Disorder overview. Abstract :.

Stephan Glund, Viktoria Moschetti et al – A randomized study in healthy volunteers to imvestigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to …

1 Dr. Stephan Glund, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany, Tel.: + , Fax: + , ... › article

... Stephan Glund 2 , Atul Deshmukh 2 , Ditte K. Klein 1 , Yun Chau Long 2 , Thomas E. Jensen 1 , Sebastian B. Jørgensen 1 , Benoit Viollet › ful...

Stephan Glund, Paul A. Reilly, Joanne van Ryn, Joachim Stangier> ;Clinical Pharmacokinectics Feb 1. Effect of Age and Renal Function on Idarucizumab ...

... very first clinical study," said the study's lead author, Stephan Glund, a researcher with Boehringer Ingelheim, the drug company that makes Pradaxa. › art

Patients with diabetes -- but not their nondiabetic counterparts -- had lower event rates following chelation therapy. Also, antidotes for the new oral...

... Ippei Ikushima, Wouter Haazen, Akiko Harada, Viktoria Moschetti, Susumu Imazu, Paul A. Reilly, Benjamin Lang, Joachim Stangier, Stephan Glund. › our-journals

Yun Chau Long | Stephan Glund | Pablo M Garcia-Roves | Juleen R Zierath. The Journal of biological chemistry | The metabolic property of skeletal ... › ...

Stephan Glund, Joachim Stangier, Joanne Ryn, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina Smet, Dietmar Gansser, Stephen Norris, Benjamin ...

Yun Chau Long, Stephan Glund, Pablo M. Garcia-Roves, Juleen R. Zierath. Journal of Biological Chemistry. Volume 282 Issue 3 Pages (January 2007). › article › ppt

Paul A. Reilly, PhD, Joanne van Ryn, PhD, Oliver Grottke, MD, PhD, Stephan Glund, PhD, Joachim Stangier, PhD. The American Journal of Medicine. › article › ppt

Sake J van der Wall, Renato D. Lopes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, ... › pub

Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Cro… Stephan Glund, Joachim Stangier, Joanne Ryn, Michael Schmohl, more · Clinical Pharmacokinetics > > 56 >